Using fecal immmunochemical cartridges for gut microbiome analysis within a colorectal cancer screening program
ABSTRACTThe colorectal cancer (CRC) screening program B-PREDICT is an invited two-stage screening project using a fecal immunochemical test (FIT) for initial screening followed by a colonoscopy for those with a positive FIT. Since the gut microbiome likely plays a role in the etiology of CRC, microb...
Main Authors: | Stefanie Brezina, Martin Borkovec, Andreas Baierl, Fabienne Bastian, Andreas Futschik, Nikolaus Gasche, Thomas Gruenberger, Michael Hallas, Christian Jannsen, Gernot Leeb, Rebecca Lutz, Barbara Sladek, Andrea Gsur |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2023-12-01
|
Series: | Gut Microbes |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/19490976.2023.2176119 |
Similar Items
-
Colorectal Cancer Study of Austria (CORSA): A Population-Based Multicenter Study
by: Andrea Gsur, et al.
Published: (2021-07-01) -
Evaluation of the “Burgenland PREvention trial of colorectal cancer Disease with ImmunologiCal Testing” (B-PREDICT)—a population-based colorectal cancer screening program
by: Stefanie BREZINA, et al.
Published: (2024-04-01) -
Untargeted Metabolomics Reveals Major Differences in the Plasma Metabolome between Colorectal Cancer and Colorectal Adenomas
by: Tanja Gumpenberger, et al.
Published: (2021-02-01) -
Fecal microbiome change in patients with ulcerative colitis after fecal microbiota transplantation
by: A. Y. Tikunov, et al.
Published: (2020-04-01) -
Diversity Census of Fecal Microbiome in Horses
by: Seul Lee, et al.
Published: (2019-09-01)